Skip to main content

SATURNA CAPITAL CORP

Position in GSK — GSK plc

CIK 1316617 BELLINGHAM, WA

Position in GSK

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$1,840,365
+$410,261 QoQ
Shares Held
33,346
+14.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2022
15 quarters on record
Voting authority Sole 65.97492952677982.ToString("F0")% Shared 0.ToString("F0")% None 34.025070473220175.ToString("F0")%

Common Shares in GSK Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Mar 31, 2026

SATURNA CAPITAL CORP holds $1,020,494,047 across 8 Drug Manufacturers - General names. GSK ranks #8 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 GSK
GSK plc
This page
33,346 $1,840,365

All Filings in GSK

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,840,365 33,346
2025-12-31 $1,430,104 29,162
2025-09-30 $891,254 20,650
2025-06-30 $870,067 22,658
2025-03-31 $877,461 22,650
2024-12-31 $852,264 25,200
2024-09-30 $1,117,577 27,338
2024-06-30 $979,825 25,450
2024-03-31 $1,287,900 30,042
2023-12-31 $1,090,008 29,412
2023-09-30 $955,985 26,372
2023-06-30 $984,091 27,612
2023-03-31 $923,407 25,953
2022-12-31 $911,988 25,953
2022-09-30 $5,807,157 197,321